Coalition for Epidemic Preparedness Innovations (CEPI) - Development of vaccines against diseases with epidemic potential
Project disclaimer
Description
The Coalition for Epidemic Preparedness Innovations (CEPI) was formally launched at the World Economic Forum in Davos in January 2017. It is the only international alliance with a primary focus on developing vaccines for diseases with epidemic potential. CEPI’s initial focus has been on developing vaccines against Lassa Fever, Nipah virus and Middle Eastern Respiratory Syndrome (MERS) virus.
Objectives
The aim is to fund and to support the research and development of vaccines for diseases with epidemic potential. Preparedness: - Advance access to safe and effective vaccines against emerging infectious diseases Response: - Accelerate the research, development and use of vaccines during outbreaks Sustainability: - Create durable and equitable solutions for outbreak response capacity
Location
The country, countries or regions that benefit from this Programme.
Status Implementation
The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.
Programme Spend
Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.
Participating Organisation(s)
Help with participating organisations
Accountable:Organisation responsible for oversight of the activity
Extending: Organisation that manages the budget on behalf of the funding organisation.
Funding: Organisation which provides funds.
Implementing: Organisations implementing the activity.
- Accountable
- Extending
- Funding
- Implementing
Sectors
Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.
Budget
A comparison across financial years of forecast budget and spend to date on the Programme.